CMBFX | ORTYX | CMBFX / ORTYX | |
Total Expense Ratio | 0.56 | 0.55 | 102% |
Annual Report Gross Expense Ratio | 0.60 | 0.55 | 109% |
Fund Existence | 41 years | 29 years | - |
Gain YTD | 2.745 | 2.416 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 293M | 277M | 106% |
Annual Yield % from dividends | 2.48 | 3.23 | 77% |
Returns for 1 year | 2.06 | 1.67 | 124% |
Returns for 3 years | 9.23 | 7.87 | 117% |
Returns for 5 years | 2.34 | 0.22 | 1,069% |
Returns for 10 years | 16.73 | 14.38 | 116% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRRYX | 16.44 | 0.02 | +0.12% |
BNY Mellon Global Real Return - Y | |||
PCCOX | 65.47 | -0.05 | -0.08% |
T. Rowe Price U.S. Equity Research I | |||
CRBRX | 14.10 | -0.15 | -1.05% |
Columbia Acorn Inst2 | |||
FMDCX | 16.29 | -0.18 | -1.09% |
Federated Hermes Mid-Cap Index Svc | |||
CWSIX | 14.88 | -0.23 | -1.52% |
Carillon Chartwell Small Cap Value I |